Introduction: The Complexity of Antipsychotic Discontinuation The decision to initiate antipsychotic medication is often complex, balancing symptomatic relief against potential side effects. However, the subsequent process of discontinuation or dose reduction presents an equally formidable, and often poorly managed, challenge for both patients and clinicians. While many individuals may benefit significantly from these medications, long-term […]
Introduction to Antipsychotic Medication Adherence Antipsychotic medication adherence refers to the degree to which a patient’s behavior concerning the timing, dosage, and frequency of taking prescribed antipsychotic medication corresponds with the recommendations agreed upon by the prescribing clinician. This concept is fundamentally critical in the long-term management of severe mental illnesses, most notably schizophrenia and […]
Defining Attitudes Toward Antipsychotic Medication Attitudes toward antipsychotic medication represent a complex constellation of beliefs, emotional responses, and behavioral intentions that an individual holds regarding the use and necessity of these pharmacological agents. These attitudes are not static; rather, they are dynamic constructs shaped by personal experience, cultural context, and the quality of the therapeutic […]
Introduction to Second-Generation Antipsychotics (SGAs) The introduction of Second-Generation Antipsychotics (SGAs), often referred to as atypical antipsychotics, marked a significant paradigm shift in the pharmacological management of severe mental illnesses, primarily schizophrenia, bipolar disorder, and treatment-resistant depression. Unlike their predecessors, the First-Generation Antipsychotics (FGAs), SGAs were initially heralded for their reduced propensity to induce extrapyramidal […]